Scientists have identified a molecule that can delay the onset of MS

Scientists at the University of Chicago have identified a small molecule likely to delay the onset of multiple sclerosis in the brain and other parts of the central nervous system, thus contributing to the development of multiple sclerosis. emergence of a new treatment of the disease.

This molecule works by prolonging the integrated integrated response, which reduces the damage caused by inflammation to myelin-producing cells.

"A small molecule called Sephin1 can delay damage to the myelin envelope without causing any adverse effects," said Dr. Yanan Chin, a professor of neurosurgery at the university.

"Multiple sclerosis destroys the myelin envelope that protects nerve fibers, causing nerve cell damage to the central nervous system," Qin said.

Multiple sclerosis affects the nervous system and its symptoms vary from person to person. The symptoms of the disease can not be predicted and depend to a large extent on the location of the central nervous system, which includes the brain, spinal cord and optic nerves. Sufferers generally suffer from fatigue, poor vision, poor coordination and balance, speech and memory problems.

Statistics show that at least 2.3 million people worldwide have MS.